Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas

被引:17
作者
Elizalde, PV
Lanari, C
Molinolo, AA
Guerra, FK
Balaña, ME
Simian, M
Iribarren, AM
Charreau, EH
机构
[1] Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina
[2] Inst Invest Ingn Genet & Biol Mol, INGEBI, RA-1428 Buenos Aires, DF, Argentina
关键词
D O I
10.1016/S0960-0760(98)00123-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of the insulin-like growth factors (IGFs) system was investigated in hormone-dependent (HD) and -independent (HI) in vivo lines of the medroxyprogesterone acetate (MPA)-induced mammary tumor model in Balb/c mice. IGF-II protein and message showed a three- to four-fold increase in HD lines growing in MPA-treated mice, as compared with HD tumors growing in untreated mice. Progression to a hormone-independent phenotype in all these lines was accompanied by a high constitutive expression of IGF-II. Similar IGF-I mRNA levels were detected in HD and HI lines. Both IGF-I and -II messages arose from the malignant epithelial cells, as shown by in situ hybridization studies. A significant decrease in Man-6P/type II IGF-R content was detected in HD tumors growing in MPA-treated mice as compared with HD lines growing in untreated mice. On the other hand, in HI tumors, notwithstanding high IGF-II synthesis, the levels of Man-6P/type II IGF-R remain high. Competitive inhibition and affinity labeling studies showed an almost exclusive binding of IGF-II to Man-6P/type II IGF-R on tumor membranes. The involvement of IGFs in the growth of epithelial primary cultures of the C4-HD line was evaluated. Exogenous IGF-I potentiated MPA stimulatory effect at concentrations of 50-100 ng/ml. Treatment of C4-HD cells with antisense oligodeoxynucleotides (ASODNs) to type I IGF-R and to IGF-II RNA resulted in a dose-dependent inhibition of MPA-mediated cell proliferation. The inhibition caused by IGF-II ASODNs could not be overcome by the addition of IGF-II up to 150 ng/ml. ASODNs to type I IGF-R at 40 mu g/ml reduced by 75% the number of type I IGF-R; ASODNs to IGF-II at 1 mu M decreased by 83% the levels of IGF-II protein. Our results provide support for the involvement of IGF-I and -II in MPA-induced mammary tumor growth by autocrine pathways. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:305 / 317
页数:13
相关论文
共 52 条
[21]  
2-5
[22]   MANNOSE 6-PHOSPHATE INSULIN-LIKE GROWTH-FACTOR-II RECEPTOR FAILS TO INTERACT WITH G-PROTEINS - ANALYSIS OF MUTANT CYTOPLASMIC-RECEPTOR DOMAINS [J].
KORNER, C ;
NURNBERG, B ;
UHDE, M ;
BRAULKE, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) :287-295
[23]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[24]   MAMMARY ADENOCARCINOMAS INDUCED BY MEDROXYPROGESTERONE ACETATE - HORMONE DEPENDENCE AND EGF RECEPTORS OF BALB/C INVIVO SUBLINES [J].
LANARI, C ;
KORDON, E ;
MOLINOLO, A ;
PASQUALINI, CD ;
CHARREAU, EH .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (05) :845-850
[25]   PROCESSING OF INSULIN-LIKE GROWTH FACTOR-II (IGF-II) BY HUMAN BREAST-CANCER CELLS [J].
LEE, AV ;
DARBRE, P ;
KING, RJB .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1994, 99 (02) :211-220
[26]  
MANNI A, 1994, CANCER RES, V54, P2934
[27]  
MANNI A, 1990, CANCER RES, V50, P7179
[28]   GROWTH-FACTOR INVOLVEMENT IN THE MULTIHORMONAL REGULATION OF MCF-7 BREAST-CANCER CELL-GROWTH IN SOFT AGAR [J].
MANNI, A ;
WRIGHT, C ;
BUCK, H .
BREAST CANCER RESEARCH AND TREATMENT, 1991, 20 (01) :43-52
[29]   ESTRADIOL DOWN-REGULATES THE MANNOSE-6-PHOSPHATE INSULIN-LIKE GROWTH FACTOR-II RECEPTOR GENE AND INDUCES CATHEPSIN-D IN BREAST-CANCER CELLS - A RECEPTOR SATURATION MECHANISM TO INCREASE THE SECRETION OF LYSOSOMAL PROENZYMES [J].
MATHIEU, M ;
VIGNON, F ;
CAPONY, F ;
ROCHEFORT, H .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (06) :815-822
[30]   INTERACTIONS OF CATHEPSIN-D AND INSULIN-LIKE GROWTH FACTOR-II (IGF-II) ON THE IGF-II MANNOSE-6-PHOSPHATE RECEPTOR IN HUMAN BREAST-CANCER CELLS AND POSSIBLE CONSEQUENCES ON MITOGENIC ACTIVITY OF IGF-II [J].
MATHIEU, M ;
ROCHEFORT, H ;
BARENTON, B ;
PREBOIS, C ;
VIGNON, F .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (09) :1327-1335